Takara Bio Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
29,933
23,883
29,105
30,078
19,537
19,033
Total Accounts Receivable
6,234
6,691
6,789
7,425
7,989
8,563
Inventories
4,420
4,637
5,099
5,461
6,010
6,735
Other Current Assets
1,230
1,236
1,165
997
1,493
941
Total Current Assets
41,817
36,447
42,158
43,964
35,032
35,275
Net Property, Plant & Equipment
16,960
20,532
20,534
19,577
18,534
21,404
Total Investments and Advances
-
4,998
-
-
-
-
Intangible Assets
2,587
2,997
2,695
2,301
14,163
12,628
Other Assets
1,091
1,447
1,183
1,272
982
891
Total Assets
62,764
66,522
66,591
67,143
68,854
72,517
ST Debt & Current Portion LT Debt
136
57
64
47
-
Accounts Payable
1,551
1,939
1,690
1,944
1,875
Income Tax Payable
243
258
515
375
431
Other Current Liabilities
2,442
3,185
3,161
3,659
3,439
Total Current Liabilities
4,372
5,439
5,430
6,025
5,745
Long-Term Debt
230
181
130
82
-
Provision for Risks & Charges
294
475
488
622
659
Deferred Taxes
139
435
175
184
44
Other Liabilities
294
249
237
215
307
Total Liabilities
5,637
6,880
6,481
7,154
6,894
Common Equity (Total)
57,069
59,541
60,008
59,885
61,853
Total Shareholders' Equity
57,069
59,541
60,008
59,885
61,853
Total Equity
57,127
59,642
60,110
59,985
61,959
Liabilities & Shareholders' Equity
62,764
66,522
66,591
67,139
68,853
Accumulated Minority Interest
58
101
102
100
106

About Takara Bio

View Profile
Address
7-4-38 Nojihigashi
Kusatsu Shiga 525
Japan
Employees -
Website http://www.takara-bio.co.jp
Updated 07/08/2019
Takara Bio, Inc. is engaged in the development and marketing of genetic engineering technologies. It operates through the following business segments: Genetic Engineering Research, AgriBio, and Gene Medicine. The Genetic Engineering Research segment offers research reagents, scientific instruments, and contract research services that are essential for biotechnology research.